advertisement
Nagayama M 13
Showing records 1 to 13 | Display only abstracts from Nagayama M in IGR 25-1121061 The Efficacy and Safety Associated with Switching from Concomitant Brimonidine and Ripasudil, or Brimonidine or Ripasudil Monotherapy to a Fixed Combination of Brimonidine and Ripasudil in Glaucoma Patients
Onoe H; Hirooka K; Baba T; Nagayama M; Hirota A; Suzuki K; Sagara T; Mochizuki H; Kiuchi Y
Journal of clinical medicine 2024; 13: (IGR: 25-1)
106721 The Efficacy, Safety, and Satisfaction Associated with Switching from Brinzolamide or Brimonidine to Brinzolamide/Brimonidine in Open-Angle Glaucoma Patients
Onoe H; Hirooka K; Nagayama M; Mochizuki H; Hirota A; Suzuki K; Sagara T; Kiuchi Y
Journal of personalized medicine 2022; 12: (IGR: 23-3)
96144 The Efficacy, Safety and Satisfaction Associated with Switching from Brinzolamide 1% and Brimonidine 0.1% to a Fixed Combination of Brinzolamide 1% and Brimonidine 0.1% in Glaucoma Patients
Onoe H; Hirooka K; Nagayama M; Hirota A; Mochizuki H; Sagara T; Suzuki K; Okumichi H; Kiuchi Y
Journal of clinical medicine 2021; 10: (IGR: 22-3)
77115 Acute Glaucoma Attack Following Microvascular Decompression Surgery for Trigeminal Neuralgia
Amagasaki K; Nagayama M; Watanabe S; Shono N; Nakaguchi H
Neurologia Medico Chirurgica 2018; 58: 266-269 (IGR: 19-3)
74241 Effect of trabeculectomy on visual field progression in Japanese progressive normal-tension glaucoma with intraocular pressure < 15 mmHg
Naito T; Fujiwara M; Miki T; Araki R; Fujiwara A; Shiode Y; Morizane Y; Nagayama M; Shiraga F
PLoS ONE 2017; 12: e0184096 (IGR: 19-1)
66817 Sustainability of Intraocular Pressure Reduction of Travoprost Ophthalmic Solution in Subjects with Normal Tension Glaucoma
Naito T; Okuma S; Nagayama M; Mizoue S; Ozaki M; Namiguchi K; Miyamoto K; Tanito M; Yoshikawa K
Advances in Therapy 2016; 33: 435-446 (IGR: 17-4)
55661 Safety and efficacy of a fixed versus unfixed brinzolamide/timolol combination in Japanese patients with open-angle glaucoma or ocular hypertension
Nagayama M; Nakajima T; Ono J
Clinical Ophthalmology 2014; 8: 219-228 (IGR: 15-4)
12723 Relationship between findings by GDxVCC and Humphery Field Analyzer
Shimamura T; Umeda T; Izawa Y; Nagayama M; Ohtsuki H
Japanese Journal of Clinical Ophthalmology 2005; 59: 835-838 (IGR: 7-3)
11455 Clinical relevance of optineurin sequence alterations in Japanese glaucoma patients
Umeda T; Matsuo T; Nagayama M; Tamura N; Tanabe Y; Ohtsuki H
Ophthalmic Genetics 2004; 25: 91-99 (IGR: 6-3)
8755 Incidence of glaucoma in patients of collagen disease and the implication of long-term systemic corticosteroid
Nagayama M; Tamura N; Umeda T; Ohtsuki H; Yamaguchi KI; Miyawaki S
Japanese Journal of Clinical Ophthalmology 2003; 57: 119-123 (IGR: 5-1)
6496 Effect of latanoprost for glaucoma resistant to other medications
Nagayama M; Yamaguchi K-I; Tamura N; Ohtsuki H; Inoue Y; Ogo T; Higuchi A
Japanese Journal of Clinical Ophthalmology 2001; 55: 1111-1115 (IGR: 3-2)
6121 Angle-closure glaucoma as a presumed presenting sign in patients with syphilis
Matsuo T; Taira Y; Nagayama M; Baba T
Japanese Journal of Ophthalmology 2000; 44: 305-308 (IGR: 2-2)
6127 Malignant glaucoma in a case of nanophthalmos
Morizane Y; Nagayama M; Takasu I; Yamaguchi K; Ohtsuki H; Kawardshi Y
Japanese Journal of Clinical Ophthalmology 2000; 54: 1230-1234 (IGR: 2-2)
